NSE filing, NSE: UNIHEALTH. Summary written from the filing by ALFA Finder's alert engine.
Unihealth Hospitals Ltd: key numbers
- Share price
- ₹564.95
- Market cap
- ₹903.9 Cr
- Revenue (annual)
- ₹132.0 Cr
- Net profit (annual)
- ₹25.83 Cr
- P/E (TTM)
- 35.0×Sector 34.0×
- Promoter holding
- 64.82%
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Unihealth Hospitals Ltd
All →Unihealth Hospitals Annual General Meeting
Unihealth Hospitals reported postal ballot results: all three resolutions passed, covering a related-party loan-to-equity conversion with UMC Hospitals, variation of unutilised IPO proceeds, and migration from NSE Emerge to the main board. No rupee amount is stated for the approvals.
Unihealth Hospitals Business Update
Unihealth Hospitals provided free scoliosis surgeries to two underprivileged children at UMC Hospitals, Navi Mumbai with charitable foundations. No monetary value is stated.
Unihealth Hospitals Convertible Warrants
Unihealth Hospitals allotted 2,00,000 equity shares upon conversion of warrants at Rs. 151 per share, totaling Rs. 3.02 Crore.
- Value
- ₹3.02 Cr
Unihealth Hospitals Annual General Meeting
Unihealth Hospitals has issued a postal ballot notice seeking shareholder approval for a material related party transaction, IPO proceeds variation, and migration to the main board.
- Value
- ₹26.00 Cr
Unihealth Hospitals Annual General Meeting
UniHealth Hospitals Limited issued a Postal Ballot notice seeking shareholder approval for a related party transaction, IPO proceeds variation, and migration to the main board.
Unihealth Hospitals Debt & Borrowing: ₹22.9 Cr
UniHealth provided a corporate guarantee of ₹22.9 Crore to Bank of India (Uganda) Limited for credit facilities sanctioned to its subsidiary, Victoria Hospital Limited, Uganda.
- Value
- ₹22.90 Cr
- From
- Bank of India (Uganda) Limited
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.